Ardsley Advisory Partners LP Boosts Stake in Surgery Partners, Inc. (NASDAQ:SGRY)

Ardsley Advisory Partners LP boosted its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 6.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 270,200 shares of the company's stock after purchasing an additional 15,200 shares during the quarter. Ardsley Advisory Partners LP owned about 0.21% of Surgery Partners worth $5,720,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of SGRY. American Century Companies Inc. boosted its holdings in shares of Surgery Partners by 223.9% in the 4th quarter. American Century Companies Inc. now owns 1,399,756 shares of the company's stock worth $29,633,000 after purchasing an additional 967,534 shares during the period. Norges Bank purchased a new position in shares of Surgery Partners in the 4th quarter valued at $15,796,000. Dimensional Fund Advisors LP increased its position in shares of Surgery Partners by 18.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,577,861 shares of the company's stock worth $75,739,000 after purchasing an additional 563,812 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Surgery Partners in the fourth quarter worth $10,130,000. Finally, Pentwater Capital Management LP acquired a new position in shares of Surgery Partners in the fourth quarter valued at about $8,997,000.

Insider Activity at Surgery Partners

In related news, CFO David T. Doherty sold 13,641 shares of the business's stock in a transaction on Friday, February 7th. The shares were sold at an average price of $25.61, for a total value of $349,346.01. Following the completion of the sale, the chief financial officer now directly owns 108,862 shares of the company's stock, valued at $2,787,955.82. The trade was a 11.14 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Marissa Brittenham sold 3,156 shares of Surgery Partners stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the sale, the insider now owns 63,408 shares in the company, valued at $1,527,498.72. This trade represents a 4.74 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 106,365 shares of company stock valued at $2,711,255 over the last three months. 2.30% of the stock is owned by corporate insiders.

Surgery Partners Stock Down 1.6 %

Shares of NASDAQ SGRY traded down $0.37 during mid-day trading on Thursday, hitting $22.79. The company had a trading volume of 492,498 shares, compared to its average volume of 1,085,971. The business's 50-day simple moving average is $22.67 and its 200 day simple moving average is $23.60. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. Surgery Partners, Inc. has a 1-year low of $19.50 and a 1-year high of $33.97. The company has a market capitalization of $2.92 billion, a PE ratio of -47.48, a price-to-earnings-growth ratio of 19.21 and a beta of 1.96.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating analysts' consensus estimates of $0.38 by $0.01. The company had revenue of $864.40 million for the quarter, compared to the consensus estimate of $828.09 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. On average, analysts predict that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on SGRY. Royal Bank of Canada reiterated an "outperform" rating and set a $35.00 price objective on shares of Surgery Partners in a research note on Tuesday, March 25th. Benchmark reissued a "buy" rating and issued a $35.00 price target on shares of Surgery Partners in a report on Monday, April 21st. Finally, Macquarie dropped their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research note on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $34.75.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.